Newsbenzinga
Ideaya Biosciences Enrolls First Patient In Its Phase 1 Trial Of IDE892 In Combination With IDE397 In Mtap-deleted Pancreatic And Lung Cancers
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…